XYREM (SODIUM OXYBATE) ORAL SOLUTION CIII
Live / Registered — Registered and renewed (as of 15 Sept 2025)
What this means for you
Registered since 17 May 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 May 2025).
Record
- Serial number
- 76427104
- Registration number
- 2952351
- Mark type
- Design + words
- Filed
- 02 Jul 2002
- Published for opposition
- 31 Dec 2002
- Registered
- 17 May 2005
- Next maintenance due
- 17 May 2025
- Attorney of record
- Michael Olsen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of sleep disorders
Owner
- JAZZ PHARMACEUTICALS, INC., Palo Alto, CA, US
- JPI Commercial, LLC, Palo Alto, CA, US
- Orphan Medical, Inc., Minnetonka, MN, US
- Orphan Medical, Inc., Minnetonka, MN, US
- Orphan Medical, Inc., Minnetonka, MN, US
Prior registrations
Prosecution history
- 11 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Nov 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Sept 2025 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 15 Sept 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 May 2025 — TEAS SECTION 8 & 9 RECEIVED
- 17 May 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 26 May 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 15 Jun 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Jun 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Mar 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED